KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $4.1 billion.

  • Charles River Laboratories International's Total Liabilities fell 270.9% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year decrease of 270.9%. This contributed to the annual value of $4.0 billion for FY2024, which is 1136.98% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Total Liabilities is $4.1 billion, which was down 270.9% from $4.2 billion recorded in Q2 2025.
  • Charles River Laboratories International's Total Liabilities' 5-year high stood at $4.8 billion during Q2 2022, with a 5-year trough of $3.6 billion in Q1 2021.
  • Its 5-year average for Total Liabilities is $4.4 billion, with a median of $4.4 billion in 2022.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 3972.14% in 2021, then crashed by 1136.98% in 2024.
  • Charles River Laboratories International's Total Liabilities (Quarter) stood at $4.4 billion in 2021, then rose by 3.32% to $4.6 billion in 2022, then dropped by 0.94% to $4.5 billion in 2023, then fell by 11.37% to $4.0 billion in 2024, then increased by 1.06% to $4.1 billion in 2025.
  • Its last three reported values are $4.1 billion in Q3 2025, $4.2 billion for Q2 2025, and $4.3 billion during Q1 2025.